| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Sphingolipid metabolism integrated pathway 0.8774805583852541 2.849376824692268 0.0043804963974827 0.9256484217283588 0.3571287134885566 8 Q06136,Q13510,Q96G23,Q16739,O95470 5 |
| Sphingolipid metabolism overview 0.8774805583852541 2.849376824692268 0.0043804963974827 0.9256484217283588 0.3571287134885566 8 Q06136,Q13510,Q96G23,Q16739,O95470 5 |
| Sphingolipid pathway 0.8573795448962557 2.7339777351352588 0.0062574275494224 0.9756697703828652 0.3571287134885566 9 Q06136,Q13510,P04062,Q96G23,Q16739,O95470 6 |
| Electron transport chain oxphos system in mitochondria 0.5617383962515432 2.730552254021654 0.006322830869309 0.97659953857217 0.3571287134885566 46 P24539,O75964,P05141,P12235,O14949,P14406,Q9UDW1,P12236,O43676,O96000,P00403,P56385,Q7KZN9,O75306,P03886,P13073,P47985 17 |
| Sphingolipid metabolism in senescence 0.8507033476018957 2.6795555537111277 0.0073719969373242 0.9874795028138132 0.3571287134885566 10 Q06136,Q13510,P04062,Q96G23,P16278,Q16739 6 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.7565377927212451 2.602584363881633 0.0092524047990529 0.9959251474055036 0.3571287134885566 12 P48729,P42166,O60725,P55209,O75844,P42167 6 |
| Influence of laminopathies on wnt signaling 0.7605117862293161 2.303035196881538 0.0212768628478343 0.999997044477351 0.4207927345073903 8 O75844,P48729,O60725 3 |
| Metapathway biotransformation phase i and ii 0.6020432121392222 2.263143091477083 0.0236268699530233 0.999999287860822 0.4207927345073903 20 P78417,Q06520,P21964,O15217,Q8NCH0,Q16850 6 |
| Metabolism of spingolipids in er and golgi apparatus 0.9186003683241196 2.0172502317753 0.0436694064208413 0.999999999996689 0.4987669940908603 4 Q06136,Q16739,O95470 3 |
| Degradation pathway of sphingolipids including diseases 0.7996471406662965 2.0145275018640008 0.0439541804346923 0.999999999997224 0.4987669940908603 6 P06865,P16278,P06280,P17900 4 |
| Mitochondrial complex iv assembly 0.6764907574787742 1.991652060259954 0.046409247074669 0.9999999999993944 0.5087828568185945 11 P14406,Q7KZN9,P00403,P20674,P13073 5 |
| Nonalcoholic fatty liver disease 0.4939112505569476 1.9701546439633468 0.0488206498898751 0.9999999999998648 0.5104545647169002 41 O14949,P14406,Q9P0J0,Q96J02,Q9UDW1,O43676,O96000,P49840,P00403,O75306,P13073,P47985 12 |
| Mitochondrial complex iii assembly 0.7032871844573254 1.9673011987722793 0.0491484969406474 0.9999999999998896 0.5104545647169002 10 O14949,Q6DKK2,Q9BRT2,Q9UDW1 4 |
| Kennedy pathway from sphingolipids 0.8987108655616869 1.9392645843810397 0.0524691289680057 0.999999999999986 0.5176954058176563 4 Q9UG56,P35790,O95470 3 |
| Vitamin d receptor pathway 0.6928589838735938 1.9145995680325052 0.0555435902724299 0.999999999999998 0.5390459908406315 10 Q96KA5,Q06520,P20020 3 |
| Glycosaminoglycan degradation 0.7713376835690521 1.8406092564639671 0.065678840291552 1.0 0.5848922969545578 5 P06865,P16278 2 |
| Ccl18 signaling pathway 0.7122646253614893 1.83359165852773 0.0667146313684454 1.0 0.5848922969545578 7 P08670,Q86UE4 2 |
| Oxidation by cytochrome p450 0.8614568713322016 1.7916839041712913 0.073183614291286 1.0 0.5848922969545578 4 O43169,Q16850 2 |
| Ciliopathies 0.5558499652133592 1.7721620914418257 0.0763676543349167 1.0 0.5848922969545578 16 O43924,Q15555,Q15051,Q86Y56,Q13432,Q8NCM8 6 |
| Cholesterol biosynthesis with skeletal dysplasias 0.742463601690713 1.7610164293005182 0.0782356223068549 1.0 0.5848922969545578 6 Q16850,Q15392,O75845 3 |
| Familial partial lipodystrophy fpld 0.7412853200136429 1.7557244561173242 0.079135468848225 1.0 0.5848922969545578 6 O60725 1 |
| Fluoropyrimidine activity 0.6603449810149316 1.748357976410896 0.0804020598685313 1.0 0.5848922969545578 10 P00374,Q06203,P31350 3 |
| Mitochondrial complex i assembly model oxphos system 0.5178763020713749 1.7437450459741952 0.0812035567871498 1.0 0.5848922969545578 21 Q9NPL8,Q96CU9,Q9P0J0,O43676,O75306,P03886 6 |
| Alzheimers disease 0.4281850542277051 1.6924423912531903 0.0905616554825241 1.0 0.6307352946547564 77 P49721,P48729,Q9H0B6,P07384,P49720,P21796,Q9NQC3,O95197,P28072,P12236,Q9Y277,P20618,P45880,P12235 14 |
| Omega3 omega6 fatty acid synthesis 0.7117723647165564 1.6223308136547343 0.1047325343557097 1.0 0.6668876883033732 6 O15254,O95864 2 |
| Allograft rejection 0.6213055052884271 1.6032856989078337 0.1088715923913725 1.0 0.6784419231125532 8 P08183,P08670,Q9BY49,P10321,P49327 5 |
| Alzheimers disease and mirna effects 0.4205498774370607 1.596766683306928 0.1103177250868574 1.0 0.6791277948578561 78 P49721,P48729,Q9H0B6,P07384,P49720,P21796,Q9NQC3,O95197,P28072,P12236,Q9Y277,P20618,P45880,P12235 14 |
| Progeriaassociated lipodystrophy 0.6220927706495789 1.5780561896233325 0.1145527017115051 1.0 0.6791277948578561 9 O60725 1 |
| Pregnane x receptor pathway 0.6957116556930493 1.503506202591675 0.1327085586790184 1.0 0.7274395068331381 5 Q06520 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4897954228101456 1.496954703486914 0.1344050447120848 1.0 0.7286425497049768 20 O75845,Q14739,Q15392,Q15800,Q16850 5 |
| Glycerophospholipid biosynthetic pathway 0.7782688766114045 1.4559911863521209 0.1453950560756549 1.0 0.7476140893174884 4 O00116,P48651,Q9BTU6 3 |
| Spinal cord injury 0.4915601535138428 1.424806467154943 0.1542131523821479 1.0 0.7484422424428132 18 P62942,Q08722,Q9NQC3 3 |
| Nucleotide metabolism 0.5152946697742211 1.4074404336162436 0.1592968286280311 1.0 0.7484422424428132 13 P00374,P31350 2 |
| Proteoglycan biosynthesis 0.97165991902834 1.349762838658656 0.1770920685036088 1.0 0.8002939278941712 2 Q8NCH0 1 |
| Serine metabolism 0.6087353478859119 1.3298391217703431 0.1835712830390665 1.0 0.8095872907453192 7 P34896,P00374,P34897,O43175 4 |
| Nanomaterial induced apoptosis 0.6465047810025198 1.322316138943913 0.1860629008103473 1.0 0.8099208623509239 6 O95831,O43464,Q9NR28 3 |
| Omega9 fatty acid synthesis 0.6532275549757731 1.3106055326318424 0.1899910690624322 1.0 0.8111885180097008 5 O95864 1 |
| Oxidative phosphorylation 0.4439246125538608 1.3023503877179372 0.19279663409469 1.0 0.8111885180097008 24 P24539,O75964,Q15904,P56385,O75306,P03886 6 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6512712677274065 1.3016814837243798 0.1930252918698869 1.0 0.8111885180097008 5 Q9BXK5,Q07820 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7368654761547477 1.2867008288641482 0.1981985840782667 1.0 0.8168597817154506 4 P09601 1 |
| Ferroptosis 0.4418406035827642 1.2834247142465378 0.199343319946557 1.0 0.8168597817154506 23 P09601,Q9Y277,Q96QD8,P45880 4 |
| Myometrial relaxation and contraction pathways 0.4769172910085839 1.2525631772841623 0.2103647227602525 1.0 0.8302394391604633 16 P78417,P62258,P16615,Q9UBI6,P10644 5 |
| Vitamin d metabolism 0.8771348356909712 1.2351730886605152 0.2167660925735752 1.0 0.8389986365743268 3 P04062 1 |
| Calcium regulation in cardiac cells 0.4421245562753959 1.1951729253166286 0.232019474403577 1.0 0.8779189881964683 21 P20020,P10644 2 |
| Constitutive androstane receptor pathway 0.5765504306243178 1.1697563372831177 0.2420990392966209 1.0 0.890202678655898 7 Q06520 1 |
| Mthfr deficiency 0.6070099038119263 1.1385025217666591 0.2549107064725988 1.0 0.9258106639986412 6 P35790 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.5358220290603488 1.1195281248167956 0.2629148993091883 1.0 0.9320393534696284 9 Q86UE4 1 |
| Urea cycle and related diseases 0.9043062200956946 1.0952280565787065 0.2734167369468219 1.0 0.9367291187222258 2 Q9Y619 1 |
| Cellular proteostasis 0.6854001496589504 1.0758466178770874 0.2819958593489635 1.0 0.9431725917208272 4 Q9UHV9 1 |
| 15q112 copy number variation syndrome 0.6797135698490681 1.0526124516199256 0.2925186480379198 1.0 0.9567460753505443 4 Q7L576,Q06787 2 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.5858243107948613 1.039693471569188 0.2984823346344512 1.0 0.9633594734726588 6 Q13177 1 |
| Disorders of folate metabolism and transport 0.5137246985227467 1.0319301124817437 0.3021048582300429 1.0 0.9649286469406751 8 P00374,P31939,P34897 3 |
| Drug induction of bile acid pathway 0.8818549871181471 1.0116362611421004 0.3117120015055521 1.0 0.971228973112036 2 Q06520 1 |
| Vitamin dsensitive calcium signaling in depression 0.58617911594696 1.0041699914661883 0.3152966837256157 1.0 0.976729579222778 5 Q8NB78 1 |
| Gastric cancer network 2 0.4476378411484008 0.9996058129776932 0.3175013088999163 1.0 0.976729579222778 14 Q9HB71,Q86UE4 2 |
| Disruption of postsynaptic signaling by cnv 0.5297261624470746 0.936164386866752 0.3491885562329191 1.0 0.979713863933119 7 Q7L576,Q06787 2 |
| Camkk2 pathway 0.5048066296575178 0.921992139829702 0.3565326756291029 1.0 0.9833489761480448 10 P09601 1 |
| Proximal tubule transport 0.486934014335564 0.8884205250950614 0.3743145887437238 1.0 0.9888220563393952 8 P08183,Q9Y5K8,P05023 3 |
| Genes related to primary cilium development based on crispr 0.4744948089626143 0.8684367499742428 0.3851552837846292 1.0 0.9888220563393952 11 Q8NCM8,P63167,Q7Z392,A0AVF1 4 |
| T cell receptor and costimulatory signaling 0.8413691571586327 0.8636464509911334 0.3877821385114082 1.0 0.9888220563393952 2 P48729 1 |
| Neural crest cell migration in cancer 0.5466584792013437 0.8577620750768824 0.3910238552512093 1.0 0.9888220563393952 6 Q13177 1 |
| Adipogenesis 0.4690499180413885 0.8375642552639045 0.4022754751651565 1.0 0.9888220563393952 11 P43490,O75844,P49327,O14654 4 |
| Triacylglyceride synthesis 0.7569955817378508 0.7933577348902605 0.4275694279578066 1.0 0.9888220563393952 3 O00116,Q9NUQ2 2 |
| Nephrotic syndrome 0.4097560823043491 0.7323784876269245 0.4639375853816023 1.0 1.0 13 Q14108,O75844 2 |
| Vitamin a and carotenoid metabolism 0.724114076498622 0.6782433422819255 0.4976174156796085 1.0 1.0 3 Q8WTV0 1 |
| Apoptosis modulation and signaling 0.390033437133282 0.6256691456003938 0.5315319750157035 1.0 1.0 14 O95831,Q9NR28,Q07820,O43464 4 |
| Network map of sarscov2 signaling pathway 0.3575665821133651 0.599227899384526 0.5490209204983598 1.0 1.0 22 Q96AX1,Q9H269,Q7Z434,Q08380,Q96J02,P42224,Q07021,P31350 8 |
| Mitochondrial immune response to sarscov2 0.4346793203464722 0.5817604708074523 0.5607280334120643 1.0 1.0 9 Q9BQ95,P35232,Q7Z434,Q99623,O94826 5 |
| Pi3kakt signaling pathway 0.3510459758453677 0.5795274512086687 0.56223332940907 1.0 1.0 30 Q16513,Q9UBI6,P30154,P62993,P30153,Q07820,P14625,P13807,Q16543 9 |
| Hippo signaling regulation pathways 0.4043061039753994 0.5776557924055196 0.5634965310917199 1.0 1.0 12 P10644 1 |
| Cholesterol biosynthesis pathway 0.4023697502728021 0.5663951198251767 0.57112521151309 1.0 1.0 12 Q16850,Q15800 2 |
| Familial hyperlipidemia type 4 0.688030694209252 0.5571934990492561 0.577395230918974 1.0 1.0 3 Q9UBV2 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.6848306332842427 0.5467831021138237 0.5845277535545268 1.0 1.0 3 O94826,Q7Z434 2 |
| Sars coronavirus and innate immunity 0.6848306332842425 0.5467831021138231 0.5845277535545272 1.0 1.0 3 P42224,Q7Z434 2 |
| Immune response to tuberculosis 0.7471475892528558 0.5426468497154429 0.5873729755757218 1.0 1.0 2 Q03518 1 |
| Endothelin pathways 0.4479368597145744 0.5381637494758408 0.5904640042364919 1.0 1.0 7 P00403,P42892 2 |
| Vitamin b12 metabolism 0.4132146600970718 0.5039064127359193 0.6143271440058007 1.0 1.0 8 P34897,Q8WTV0 2 |
| Interferon type i signaling pathways 0.3668639053254454 0.4960519556142237 0.6198577549300284 1.0 1.0 15 P62753,P63244,P46108,P63000,P46109,Q99873,P60842,P42224,P42345,P23588,P06730,Q16539,Q53EL6,P40763 14 |
| Neuroinflammation 0.6638438880706934 0.4800364942252098 0.6312014434914042 1.0 1.0 3 P00403,Q16539 2 |
| Folate metabolism 0.3613160772312546 0.4782694196194613 0.6324584588942697 1.0 1.0 16 P00374 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.7261685682738352 0.4778811608564528 0.63273479079531 1.0 1.0 2 P08183 1 |
| Ras signaling 0.3439584877687156 0.4708165459328856 0.6377717477868614 1.0 1.0 21 P61020,P0DP25,P11233,P62330,P20339,Q13177,P55196,Q06124,Q9NWH9,Q9UBI6,P61586,P51148,P60953,P63000,P17612,P62993,Q13043,P28482,Q96KP1,P27361 20 |
| Amyotrophic lateral sclerosis als 0.4092275458672033 0.4226623364255092 0.6725416387283512 1.0 1.0 10 P07197,Q9BUN8,O96008 3 |
| Apoptosis 0.4076984601737272 0.4151407609177446 0.6780388618350046 1.0 1.0 10 Q07820,Q9NR28 2 |
| Fragile x syndrome 0.3291866736396133 0.4102917155238468 0.6815919685346494 1.0 1.0 33 Q9NZ01,P09497,Q7L576,P10644,P51648 5 |
| Glycerolipids and glycerophospholipids 0.6286251308354989 0.3748589293470803 0.707765385111119 1.0 1.0 3 Q9UG56 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.6853146853146899 0.3614809541310363 0.7177399402301443 1.0 1.0 2 P08195 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.427939550313296 0.3400437967840717 0.7338235459399773 1.0 1.0 6 Q92769,Q8WX92,P50750,Q13547,Q8IXH7 5 |
| 7oxoc and 7betahc pathways 0.3839287631074288 0.3312778481661023 0.7404346221294871 1.0 1.0 9 O15118 1 |
| Tryptophan metabolism 0.3395764817045857 0.3052449775506364 0.7601795788026027 1.0 1.0 13 Q15392 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6023904042177852 0.3030854344339316 0.7618247540534715 1.0 1.0 3 Q07820 1 |
| Ovarian infertility 0.6613912403386136 0.3002092426817365 0.764017555414011 1.0 1.0 2 P11802 1 |
| 22q112 copy number variation syndrome 0.3127480798122949 0.2790285488478799 0.7802229156937468 1.0 1.0 28 Q92973,P21964,Q9NQC3,Q9NQ50 4 |
| Glycogen synthesis and degradation 0.3256401639399875 0.2703771230358636 0.7868701380800722 1.0 1.0 17 P46020,P63151,P49840,P30154,P52789,P35573,P30153,P13807 8 |
| Tnfalpha signaling pathway 0.3205895846468525 0.2696510648281306 0.7874287109079552 1.0 1.0 19 Q16543 1 |
| Rala downstream regulated genes 0.3979366249079031 0.2224769125405157 0.8239426440590765 1.0 1.0 5 P63000,P11233,Q96KP1,P16989 4 |
| Hippomerlin signaling dysregulation 0.3179100803445698 0.2124697395752562 0.8317405831578013 1.0 1.0 16 Q13177,P10644 2 |
| Pancreatic adenocarcinoma pathway 0.3156920799407829 0.2109991366345744 0.8328879450560152 1.0 1.0 17 Q16611,Q07812,P60953,P63000,P27361,P04637,P42224,P11802,P42345,Q13177,Q00534,P40763,P11233,P61586,P36507,P28482 16 |
| Praderwilli and angelman syndrome 0.4473452680780957 0.2084559097470766 0.8348730053244013 1.0 1.0 4 Q7L576,P11802 2 |
| Complement system in neuronal development and plasticity 0.3594193248979317 0.1926575795401011 0.8472271475986435 1.0 1.0 10 P10909,O43464,Q9NR28 3 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3434157137587585 0.1829996077673901 0.8547983263770664 1.0 1.0 8 P51148,P20339,P61020,Q8WUM4,O14964,P31943,P27361 7 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3124149000409663 0.1813639434563919 0.8560819184674118 1.0 1.0 16 P42166,Q9BTV4,Q14739,P62993,P50402,P42167 6 |
| Pdgf pathway 0.3437961595273255 0.1787371504815245 0.8581440970129395 1.0 1.0 11 P60953,P63000,P53365,P42224,P00403,P62993,P40763,P61586,Q06124,P27361 10 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3426883308714938 0.1737874916113407 0.8620324750532227 1.0 1.0 11 Q00653,Q9BTU6,P62753,P27361,P42224,P42345,Q16539,P40763,Q06124,P28482 10 |
| Il3 signaling pathway 0.3435424354243604 0.1553385809111008 0.8765544015782045 1.0 1.0 9 P27348,P46109,P17612,P31946,P62993,P40763,Q06124,P27361 8 |
| Photodynamic therapyinduced ap1 survival signaling 0.3564145648333249 0.1540795089544388 0.8775470448184615 1.0 1.0 7 P49327,Q07820 2 |
| Il2 signaling pathway 0.3424354243542492 0.1509207499019446 0.880038231914108 1.0 1.0 9 P62753,P46109,P27361,P42224,P62993,P40763,Q06124,P28482 8 |
| Notch signaling pathway 0.3482767829905544 0.1465208953446211 0.8835101958244802 1.0 1.0 10 Q96J02 1 |
| Apoptosis modulation by hsp70 0.5324638105856861 0.1453257508613915 0.8844536842947082 1.0 1.0 3 O95831 1 |
| Oncostatin m signaling pathway 0.3232360546730746 0.1442866226675736 0.8852741413363612 1.0 1.0 12 P62753,P36507,P27361,P04637,P62993,P42224,P42345,Q16539,P40763,Q06124,P28482 11 |
| Onecarbon metabolism 0.3053375618824495 0.1346987772889829 0.8928500399621184 1.0 1.0 15 P34896,P00374,P31939,P34897 4 |
| Nad metabolism 0.4170383658892696 0.1329048691651945 0.8942686160322519 1.0 1.0 4 P43490 1 |
| Nad biosynthetic pathways 0.4170383658892696 0.1329048691651945 0.8942686160322519 1.0 1.0 4 P43490 1 |
| Copper homeostasis 0.4137516382701112 0.1254847676824977 0.9001397833459965 1.0 1.0 4 O43819 1 |
| Egfr tyrosine kinase inhibitor resistance 0.3425618309339251 0.1237899718643749 0.9014815720329354 1.0 1.0 10 P62753,Q9NWH9,P27361,P62993,P42345,P06730,P40763,Q07812,P28482 9 |
| Follicle stimulating hormone fsh signaling pathway 0.3432890855457275 0.1092355710486389 0.913015647491244 1.0 1.0 7 P62753,P17612,P42345,Q16539,Q9UKG1,P27361 6 |
| Il9 signaling pathway 0.3421828908554608 0.1056092249661245 0.9158924052231364 1.0 1.0 7 P50750,P42224,P62993,P40763,P28482,P27361 6 |
| Glioblastoma signaling pathways 0.3359173126615 0.0982092826584957 0.9217661116042096 1.0 1.0 10 P38398,P52701,Q9NWH9,P62993,P11802,Q00534,P28482,P36507,P27361 9 |
| Orexin receptor pathway 0.2984764445496194 0.0943041263955993 0.9248675721360108 1.0 1.0 14 P31350 1 |
| Preimplantation embryo 0.3320434841904347 0.0735304582688236 0.941384007475744 1.0 1.0 7 Q92945,P05023 2 |
| Leukocyteintrinsic hippo pathway functions 0.3468485071876152 0.0678838315576055 0.9458781096081904 1.0 1.0 6 P27348,P63000,Q13043,Q16539,P61586 5 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.385060235024762 0.0674620822130243 0.9462138472385178 1.0 1.0 4 P18031 1 |
| 3q29 copy number variation syndrome 0.3164463369445382 0.06432968095622 0.9487077204082728 1.0 1.0 11 Q13177,P02786,Q8NCM8 3 |
| Il7 signaling pathway 0.3419307295504858 0.0635005877367021 0.9493678912440392 1.0 1.0 5 P42224,P40763,P28482,P27361 4 |
| Mapk cascade 0.3419307295504786 0.0635005877366851 0.9493678912440526 1.0 1.0 5 P62993,Q16539,P28482,P27361 4 |
| Base excision repair 0.2904556033485312 0.0561632384528447 0.9552117663813235 1.0 1.0 14 Q9NR33,P18887 2 |
| Epo receptor signaling 0.342056763730193 0.0552595646891659 0.9559316756207232 1.0 1.0 6 P27361,P42224,P62993,P40763,P28482 5 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.3420567637301929 0.0552595646891656 0.9559316756207236 1.0 1.0 6 P42224,P09543,Q16539,P28482,P27361 5 |
| Glial cell differentiation 0.5082811924917265 0.0531695421593359 0.9575968231117732 1.0 1.0 2 P09543 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3409509767784784 0.0524089491362774 0.9582028435388796 1.0 1.0 6 Q00653,P42224,Q16539,P28482,P27361 5 |
| Transsulfuration and onecarbon metabolism 0.2831170963617924 0.0487179360300081 0.9611440819625808 1.0 1.0 19 P00374,O43175,P34897 3 |
| Joubert syndrome 0.2880284646672557 0.0483805282220514 0.9614129773581824 1.0 1.0 15 P41208,O43924,Q13432 3 |
| Mirna regulation of prostate cancer signaling pathways 0.3354220420199068 0.0385122224612611 0.9692792865993064 1.0 1.0 6 P62993,P42345,P35222,P28482,P36507 5 |
| Complement and coagulation cascades 0.4576496199618107 0.0376100183541622 0.9699986200831064 1.0 1.0 3 P49257 1 |
| Ketogenesis and ketolysis 0.3552706877760974 0.0202089596886892 0.9838766805481008 1.0 1.0 4 O43772 1 |
| Interactions between immune cells and micrornas in tumor microenvironment 0.4486566065513521 0.0194939035249386 0.9844471004027012 1.0 1.0 2 Q00653 1 |
| Cardiac progenitor differentiation 0.3824070666176004 0.0054428254252552 0.995657275067787 1.0 1.0 2 Q16539 1 |
| Pilocytic astrocytoma 0.3651085756348993 0.0039879379745758 0.996818094294634 1.0 1.0 2 P62993 1 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.362164151637844 0.0037951732018935 0.9969718971657704 1.0 1.0 2 P09543 1 |
| Steroid biosynthesis 0.3614280456385804 0.0037491574201509 0.9970086121863586 1.0 1.0 2 P51659 1 |
|
|
